retatrutide sign up eli lilly trial Retatrutide, an experimental weight-loss drug, has not been approved Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

All GLP-1 medications carry similar pancreatitis warnings, though the exact risk may vary slightly between different medications in this class

6 science-backed ways to support GLP-1 production 1

The weight loss market has no signs of slowing down, with some reports suggesting there are nearly 160 obesity drugs currently in development by big pharma companies

Pedersen-Bjergaard U, Pramming S, Thorsteinsson B (2003) Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes

Catch up on NBC Selects in-depth coverage of tech and tools , wellness and more, and follow us on Facebook , Instagram , Twitter and TikTok to stay up to date.